The acquisition could close in the second quarter of 2021 and is subject to Federal Trade Commission approval. Hill-Rom is acquiring Bardy Diagnostics for its advanced diagnostic cardiology platform.
Hill-Rom will pay $375 million in cash, plus future payments after reaching certain commercial milestones. Hill-Rom will also acquire Bardy’s net operating losses that are around $20 million.
Bardy Diagnostics, a digital health provider of ambulatory cardiac monitoring technologies, was formed in 2013.
More articles on surgery centers:
Ohio health system acquires surgery center for $21M
2 Texas health systems suspend surgeries, others don’t
Stryker’s ASC-focused business: 3 things to know
